Blood cancers, High grade lymphoma, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at treatment for people with B cell lymphoma that had come back after treatment or continued to grow during treatment.
It was for people who had a protein called CD20 on their lymphoma cells. This is CD20 positive lymphoma.
This trial was supported by Cancer Research UK. People could join between 2018 and 2020. The team published the results in 2025.
You pronounce varlilumab var-lee-loo-mab.
Recruitment start: 1 January 2018
Recruitment end: 31 December 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Sean Hua Lim
Cancer Research UK
Celldex Therapeutics
University Hospital Southampton NHS Foundation Trust
University of Southampton
This is Cancer Research UK trial number CRUKD/17/008.
Last reviewed: 29 Apr 2026
CRUK internal database number: 14317
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
